Applied DNA Sciences (Applied DNA Sciences) Gross Margin % : 25.93% (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Applied DNA Sciences Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Applied DNA Sciences's Gross Profit for the three months ended in Dec. 2023 was $0.23 Mil. Applied DNA Sciences's Revenue for the three months ended in Dec. 2023 was $0.89 Mil. Therefore, Applied DNA Sciences's Gross Margin % for the quarter that ended in Dec. 2023 was 25.93%.

Warning Sign:

Applied DNA Sciences Inc gross margin has been in long-term decline. The average rate of decline per year is -15.8%.

The historical rank and industry rank for Applied DNA Sciences's Gross Margin % or its related term are showing as below:

APDN' s Gross Margin % Range Over the Past 10 Years
Min: 27.82 Med: 69.1 Max: 95.74
Current: 37.64

During the past 13 years, the highest Gross Margin % of Applied DNA Sciences was 95.74%. The lowest was 27.82%. And the median was 69.10%.

APDN's Gross Margin % is ranked worse than
62.5% of 216 companies
in the Medical Diagnostics & Research industry
Industry Median: 45.595 vs APDN: 37.64

Applied DNA Sciences had a gross margin of 25.93% for the quarter that ended in Dec. 2023 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for Applied DNA Sciences was -15.80% per year.

Applied DNA Sciences Gross Margin % Historical Data

The historical data trend for Applied DNA Sciences's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Applied DNA Sciences Gross Margin % Chart

Applied DNA Sciences Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Gross Margin %

Get a 7-Day Free Trial

83.71

57.17

49.66

27.82

41.39

Applied DNA Sciences Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Gross Margin %	Get a 7-Day Free Trial															45.18	40.99	43.50	10.13	25.93

Competitive Comparison of Applied DNA Sciences's Gross Margin %

For the Diagnostics & Research subindustry, Applied DNA Sciences's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Applied DNA Sciences's Gross Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Applied DNA Sciences's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Applied DNA Sciences's Gross Margin % falls into.

Applied DNA Sciences Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Applied DNA Sciences's Gross Margin for the fiscal year that ended in Sep. 2023 is calculated as

Gross Margin % (A: Sep. 2023 )	=	Gross Profit (A: Sep. 2023 )	/	Revenue (A: Sep. 2023 )
	=	5.5	/	13.367
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(13.367 - 7.834)	/	13.367
	=	41.39 %

Applied DNA Sciences's Gross Margin for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )	=	Gross Profit (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	0.2	/	0.891
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(0.891 - 0.66)	/	0.891
	=	25.93 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Applied DNA Sciences (NAS:APDN) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Applied DNA Sciences had a gross margin of 25.93% for the quarter that ended in Dec. 2023 => Competition eroding margins

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Applied DNA Sciences Gross Margin % Related Terms

Thank you for viewing the detailed overview of Applied DNA Sciences's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Applied DNA Sciences (Applied DNA Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Applied DNA Sciences Inc (NAS:APDN) » Definitions » Gross Margin %

Comparable Companies

Traded in Other Exchanges

UDJP:Germany

Address

50 Health Sciences Drive, Stony Brook, New York, NY, USA, 11790

Website

https://www.adnas.com

Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) nd ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.

Executives

Clay Shorrock	officer: Chief Legal Officer	C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Scott L Anchin	director	16990 GOLDENTOP ROAD, SUITE A, SAN DIEGO CA 92127
William W Montgomery	10 percent owner	34211 SEAVEY LOOP RD., EUGENE OR 97405
Judith Murrah	officer: Chief Information Officer	C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Beth Jantzen	officer: Chief Financial Officer	C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Yacov A Shamash	director
Robert B Catell	director	62 OSBORNE ROAD, GARDEN CITY NY 11530
John Iii Bitzer	director	C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Joseph D. Ceccoli	director	C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Elizabeth M. Ferguson	director	50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Charles S. Ryan	director	C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
James A Hayward	director, officer: Chief Executive Officer	C/O 25 HEALTH SCIENCES DRIVE, SUITE 113, NEW YORK NY 11790
Karol Gray	officer: Chief Financial Officer	C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Ming-hwa Benjamin Liang	officer: Strategic Tech. Dev. Officer	C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Yacov Shamash	director	100 ENGINEERING, STATE UNIVERSITY OF NY, STONE BROOK NY 117942200